Servier completes the acquisition of Day One Biopharmaceuticals

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Servier-Day-One-Bio

More Like This

PR Newswire associated0

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

PR Newswire associated0

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

BeOne Medicines' biologics manufacturing facility and clinical R&D center in Hopewell, NJ.

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

PR Newswire associated0

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

PR Newswire associated0

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder